Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - FLYNN JAMES E
Last Updated 
2-Jul-15
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

FLYNN JAMES E: Declared Holdings
Company/RelationshipReportedShares  Ownership
Avalanche Biotechnologies, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AAVL
(historical quotes, profile, other insiders)
5-Aug-142,197,679  Indirect
Antares Pharma, Inc.
Beneficial Owner (10% or more)
NasdaqCM:ATRS
(historical quotes, profile, other insiders)
1-Jul-1518,345,953  Indirect
AxoGen, Inc.
Beneficial Owner (10% or more)
NasdaqCM:AXGN
(historical quotes, profile, other insiders)
8-Apr-153,726,439  Indirect
CAS Medical Systems, Inc.
Beneficial Owner (10% or more)
NasdaqCM:CASM
(historical quotes, profile, other insiders)
1-Jan-153,200,000  Indirect
Dicerna Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:DRNA
(historical quotes, profile, other insiders)
25-Nov-141,774,662  Indirect
eHealth, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EHTH
(historical quotes, profile, other insiders)
6-Mar-153,264,588  Indirect
Loxo Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGM:LOXO
(historical quotes, profile, other insiders)
6-Aug-141,591,546  Indirect
Invitae Corporation Common Stoc
Beneficial Owner (10% or more)
NYSE:NVTA
(historical quotes, profile, other insiders)
18-Feb-15341,666  Indirect
Proteon Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:PRTO
(historical quotes, profile, other insiders)
27-Oct-141,255,107  Indirect
TriVascular Technologies, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TRIV
(historical quotes, profile, other insiders)
22-Apr-141,697,669  Indirect
Vanda Pharmaceuticals Inc.
Beneficial Owner (10% or more)
NasdaqGM:VNDA
(historical quotes, profile, other insiders)
15-May-154,784,157  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Jul-15 *43,836ATRS Sale at $2.10 - $2.11 per share.
(Proceeds of about $92,000)
30-Jun-15 *608,691ATRS Sale at $2.08 per share.
(Proceeds of $1,266,077)
29-Jun-15 *60,695ATRS Sale at $2.18 per share.
(Proceeds of $132,315)
26-Jun-15 *318,534ATRS Sale at $2.24 - $2.25 per share.
(Proceeds of about $715,000)
25-Jun-15 *175,200ATRS Sale at $2.25 per share.
(Proceeds of $394,200)
24-Jun-15 *263,118ATRS Sale at $2.29 - $2.34 per share.
(Proceeds of about $609,000)
23-Jun-15 *181,862ATRS Sale at $2.35 per share.
(Proceeds of $427,375)
22-Jun-15 *176,483ATRS Sale at $2.41 per share.
(Proceeds of $425,324)
19-Jun-15 *141,550ATRS Sale at $2.41 per share.
(Proceeds of $341,135)
18-Jun-15 *210,701ATRS Sale at $2.48 per share.
(Proceeds of $522,538)
17-Jun-15 *53,605ATRS Sale at $2.41 per share.
(Proceeds of $129,188)
16-Jun-15 *214,060ATRS Sale at $2.40 per share.
(Proceeds of $513,744)
15-Jun-15 *190,141ATRS Sale at $2.40 - $2.41 per share.
(Proceeds of about $457,000)
12-Jun-15 *218,617ATRS Sale at $2.43 per share.
(Proceeds of $531,239)
11-Jun-15 *339,272ATRS Sale at $2.47 - $2.48 per share.
(Proceeds of about $840,000)
15-May-15 *4,784,157VNDA Statement of Ownership
11-May-15 *21,578,318ATRS Statement of Ownership
8-Apr-15 *144,385AXGN Sale at $3.25 per share.
(Proceeds of $469,251)
6-Mar-15 *30,103EHTH Purchase at $9.52 per share.
(Cost of $286,580)
18-Feb-15 *166,666NVTA Acquisition (Non Open Market)
18-Feb-15 *175,000NVTA Purchase at $16 per share.
(Cost of $2,800,000)
10-Feb-15 *3,870,824AXGN Statement of Ownership
14-Jan-15 *1,000,000EHTH Purchase at $19.84 - $20.45 per share.
(Cost of about $20,145,000)
1-Jan-15 *1,443,200CASM Purchase at $1.65 per share.
(Cost of $2,381,280)
1-Jan-15 *1,443,200CASM Sale at $1.65 per share.
(Proceeds of $2,381,280)
23-Dec-14 *162,014VNDA Purchase at $14.23 - $14.5 per share.
(Cost of about $2,327,000)
23-Dec-14 *3,977,773VNDA Statement of Ownership
25-Nov-14 *121,965DRNA Sale at $11.50 per share.
(Proceeds of $1,402,597)
24-Nov-14 *100,000DRNA Sale at $11.54 - $11.55 per share.
(Proceeds of about $1,155,000)
21-Nov-14 *100,000DRNA Sale at $11 per share.
(Proceeds of $1,100,000)
7-Nov-14 *214,164DRNA Sale at $9 - $9.33 per share.
(Proceeds of about $1,963,000)
27-Oct-14 *691,713PRTO Purchase at $10 per share.
(Cost of $6,917,130)
27-Oct-14 *563,394PRTO Acquisition (Non Open Market)
15-Oct-14 *51,449DRNA Sale at $10.01 per share.
(Proceeds of $515,004)
14-Oct-14 *36,115DRNA Sale at $11.02 per share.
(Proceeds of $397,987)
10-Oct-14 *30,214DRNA Sale at $12 - $12.14 per share.
(Proceeds of about $365,000)
7-Aug-14 *3,131EHTH Purchase at $21.05 per share.
(Cost of $65,907)
6-Aug-14 *1,089,656LOXO Purchase at $13 - $13.05 per share.
(Cost of about $14,193,000)
6-Aug-14 *501,890LOXO Acquisition (Non Open Market)
5-Aug-14 *863,212AAVL Acquisition (Non Open Market)
5-Aug-14 *1,334,467AAVL Purchase at $17 - $27.54 per share.
5-Aug-14 *3,770EHTH Purchase at $20.99 per share.
(Cost of $79,132)
4-Aug-14 *155,470EHTH Purchase at $20.40 - $20.75 per share.
(Cost of about $3,199,000)
1-Aug-14 *1,931,917EHTH Statement of Ownership
1-Aug-14 *170,300EHTH Purchase at $19.04 - $19.4 per share.
(Cost of about $3,273,000)
22-Apr-14 *1,065,000TRIV Purchase at $11.97 - $12.29 per share.
(Cost of about $12,918,000)
22-Apr-14 *632,669TRIV Acquisition (Non Open Market)
4-Feb-14 *1,428,569DRNA Acquisition (Non Open Market)
4-Feb-14 *1,000,000DRNA Purchase at $15 per share.
(Cost of $15,000,000)
17-Jul-13 *3,200,000CASM Statement of Ownership
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?